BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate
Author:
Affiliation:
1. Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States
2. Biocon Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.1c00373
Reference36 articles.
1. The multilayered complexity of the chemokine receptor system
2. A guide to chemokines and their receptors
3. Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
4. The CCR2 receptor as a therapeutic target
5. The Expanding Therapeutic Perspective of CCR5 Blockade
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy;Reviews in Medical Virology;2024-08-27
2. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials;Biomedicine & Pharmacotherapy;2024-08
3. Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues;Frontiers in Immunology;2024-07-15
4. Angiopoietin-Like Protein 2 Expression in Tumor Cells Supports Tumor-Associated Macrophage-Induced Tumor Progression in Esophageal Cancer;Annals of Surgical Oncology;2024-07-09
5. Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer;Pharmaceutics;2024-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3